Bethany Sensenig, Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 4,475 shares at $50.31 ($228K) on 2026-02-19, disclosed to the SEC on 2026-02-23.
Open-market sale of $228k SUPN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.31 | 1,217 | $61K | 26.8% |
| 2 | $51.27 | 3,258 | $167K | 73.2% |
| Total | $51.01 avg | 4,475 | $228K | 100% |
| Filing → |